Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neridronate in Painful Knee Osteoarthritis with Bone Marrow Lesions
NCT01803360Phase 2Unknown
- Sponsor
- ASST Gaetano Pini-CTO
- Start
- Mar 2013
- Primary completion
- Jul 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in osteoarthritis (OA) comparing Neridronate Arm with Placebo Arm (2 arms). Primary endpoint: Knee pain reduction at 60 days. Status: unknown.
02
Drugs
neridronic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01803360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01803360.